Bristol-Myers Squibb Company
BMY
$48.46
$0.561.17%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 11.20B | 12.34B | 11.89B | 12.20B | 11.87B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.20B | 12.34B | 11.89B | 12.20B | 11.87B |
| Cost of Revenue | 3.02B | 3.21B | 2.86B | 2.97B | 2.91B |
| Gross Profit | 8.18B | 9.13B | 9.04B | 9.23B | 8.96B |
| SG&A Expenses | 1.58B | 1.85B | 2.08B | 1.92B | 1.97B |
| Depreciation & Amortization | 830.00M | 1.69B | 2.41B | 2.42B | 2.36B |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.67B | 9.55B | 9.70B | 9.60B | 9.58B |
| Operating Income | 3.54B | 2.80B | 2.20B | 2.60B | 2.28B |
| Income Before Tax | 2.97B | 175.00M | 1.68B | 1.29B | -11.52B |
| Income Tax Expenses | 509.00M | 99.00M | 461.00M | -398.00M | 392.00M |
| Earnings from Continuing Operations | 2.46B | 76.00M | 1.22B | 1.68B | -11.91B |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -6.00M | -4.00M | -4.00M | -4.00M | -3.00M |
| Net Income | 2.46B | 72.00M | 1.21B | 1.68B | -11.91B |
| EBIT | 3.54B | 2.80B | 2.20B | 2.60B | 2.28B |
| EBITDA | 4.19B | 4.65B | 4.83B | 5.22B | 4.83B |
| EPS Basic | 1.21 | 0.04 | 0.60 | 0.83 | -5.89 |
| Normalized Basic EPS | 1.14 | 0.76 | 0.72 | 0.82 | 0.76 |
| EPS Diluted | 1.20 | 0.04 | 0.60 | 0.83 | -5.89 |
| Normalized Diluted EPS | 1.13 | 0.75 | 0.72 | 0.82 | 0.76 |
| Average Basic Shares Outstanding | 2.03B | 2.03B | 2.03B | 2.03B | 2.02B |
| Average Diluted Shares Outstanding | 2.04B | 2.04B | 2.03B | 2.03B | 2.02B |
| Dividend Per Share | 0.62 | 0.62 | 0.60 | 0.60 | 0.60 |
| Payout Ratio | 51.22% | 1,691.67% | 100.41% | 72.44% | -10.18% |